EV/EBITDA
246.87
+2.90+1.19%
Fri, 21 Feb 2025 00:55:02 GMT
Summary
- As of February 21, 2025, VRTX EV/EBITDA is 246.87, with a rise of +2.90 (+1.19%) during the most recent trading day.
- Over the past year, VRTX EV/EBITDA has increased by +225.07 (+1032.43%).
- VRTX EV/EBITDA is now -88.44% below its all-time high of 2135.37.
Performance
VRTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VRTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.2% | +1.2% | +1.2% |
| 1 m1 month | +14.2% | +14.2% | +13.9% |
| 3 m3 months | -0.6% | +4.0% | +3.6% |
| 6 m6 months | -16.4% | -1.1% | -1.2% |
| ytdytd | +21.4% | +21.4% | +20.8% |
| 1 y1 year | +1032.4% | +21.1% | +13.8% |
| 5 y5 years | +530.4% | +96.5% | +95.2% |
VRTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.6% | 216.11 | +14.2% | |
| 3 m | 3-month | 256.85 | -3.9% | 203.43 | +21.4% |
| 6 m | 6-month | 302.84 | -18.5% | 203.43 | +21.4% |
| 1 y | 1-year | 302.84 | -18.5% | 18.46 | +1237.3% |
| 3 y | 3-year | 302.84 | -18.5% | 14.25 | +1632.4% |
| 5 y | 5-year | 302.84 | -18.5% | 12.50 | +1875.0% |
| alltime | all time | 2135.37 | -88.4% | -1976 | +112.5% |
Vertex Pharmaceuticals Incorporated EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 246.87(+21.4%) |
| 2024 | 203.43(+1296.2%) |
| 2022 | 14.57(-15.1%) |
| 2021 | 17.16(0.0%) |
| 2020 | 17.16(-50.6%) |
| 2019 | 34.77(-35.6%) |
| 2018 | 53.98(-83.2%) |
| 2017 | 320.80(+34.9%) |
| 2016 | 237.85(-414.5%) |
| 2015 | -75.63(+56.6%) |
| 2014 | -48.30(+60.1%) |
| 2013 | -30.17(-127.6%) |
| 2012 | 109.26(+109.9%) |
| 2011 | 52.05(-592.9%) |
| 2010 | -10.56(-23.6%) |
| 2009 | -13.82(+31.7%) |
| 2008 | -10.49(+46.9%) |
| Date | Value |
|---|---|
| 2007 | -7.14(-69.2%) |
| 2006 | -23.21(-14.2%) |
| 2005 | -27.04(+156.5%) |
| 2004 | -10.54(+30.1%) |
| 2003 | -8.10(-30.3%) |
| 2002 | -11.62(-44.1%) |
| 2001 | -20.80(-88.3%) |
| 2000 | -178.17(+798.5%) |
| 1999 | -19.83(+26.2%) |
| 1998 | -15.71(-68.5%) |
| 1997 | -49.94(+120.3%) |
| 1996 | -22.67(+18.3%) |
| 1995 | -19.17(+71.2%) |
| 1994 | -11.20(-128.2%) |
| 1993 | 39.73(-351.5%) |
| 1992 | -15.80(-76.9%) |
| 1991 | -68.32 |
FAQ
- What is Vertex Pharmaceuticals Incorporated EV/EBITDA?
- What is the all time high EV/EBITDA for Vertex Pharmaceuticals Incorporated?
- What is VRTX EV/EBITDA year-to-date change?
- What is Vertex Pharmaceuticals Incorporated EV/EBITDA year-on-year change?
What is Vertex Pharmaceuticals Incorporated EV/EBITDA?
The current EV/EBITDA of VRTX is 246.87
What is the all time high EV/EBITDA for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high EV/EBITDA is 2135.37
What is VRTX EV/EBITDA year-to-date change?
Vertex Pharmaceuticals Incorporated EV/EBITDA has changed by +43.44 (+21.35%) since the beginning of the year
What is Vertex Pharmaceuticals Incorporated EV/EBITDA year-on-year change?
Over the past year, VRTX EV/EBITDA has changed by +225.07 (+1032.43%)